Thymic stromal lymphopoietin receptor molecules and uses thereof

US6955895B2 · kind B2 · utility

Assignees

• Whitehead Institute For Biomedical Research · US
• THE GOVERNMENT OF THE UNITED STATES OF AMERICA · US
• Health Research Inc., Roswell Park Division · US

Inventors

• Akhilesh Pandey · Pikesville, US
• Katsutoshi Ozaki · Tochigi, JP
• Heinz Baumann · Iserlohn, DE
• Steven D. Levin · Seattle, US
• Andrew G. Farr · Seattle, US
• Warren J. Leonard · Bethesda, US
• Harvey Lodish · Brookline, US

Key dates

• Filing date: Jun 28, 2001
• Grant date: Oct 18, 2005
• Expiry date: Jun 28, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides.